middle.news
Cambium Bio secures backing for A$10.85 million Elate Ocular funding package
12:03pm on Wednesday 16th of September, 2026 AEST
•
Biotechnology
Read Story
Cambium Bio secures backing for A$10.85 million Elate Ocular funding package
12:03pm on Wednesday 16th of September, 2026 AEST
Key Points
A$7.1 million placement at A$0.48 per share
Total proposed funding package of A$10.85 million
Shares on issue would rise from 29.4 million to 44.2 million
Wu investors’ combined voting power would reach approximately 31.85%
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Cambium Bio (ASX:CMB)
OPEN ARTICLE